RT Journal Article
SR Electronic
T1 COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.16.20196071
DO 10.1101/2020.09.16.20196071
A1 Ryan M. Pace
A1 Janet E. Williams
A1 Kirsi M. Järvinen
A1 Mandy B. Belfort
A1 Christina D.W. Pace
A1 Kimberly A. Lackey
A1 Alexandra C. Gogel
A1 Phuong Nguyen-Contant
A1 Preshetha Kanagaiah
A1 Theresa Fitzgerald
A1 Rita Ferri
A1 Bridget Young
A1 Casey Rosen-Carole
A1 Nichole Diaz
A1 Courtney L. Meehan
A1 Beatrice Caffe
A1 Mark Y. Sangster
A1 David Topham
A1 Mark A. McGuire
A1 Antti Seppo
A1 Michelle K. McGuire
YR 2020
UL http://medrxiv.org/content/early/2020/09/18/2020.09.16.20196071.abstract
AB Background It is not known whether SARS-CoV-2 can be transmitted from mother to infant during breastfeeding, and if so whether the benefits of breastfeeding outweigh this risk. This study was designed to evaluate 1) if SARS-CoV-2 RNA can be detected in milk and on the breast of infected women, 2) concentrations of milk-borne anti-SARS-CoV-2 antibodies, and 3) the capacity of milk to neutralize SARS-CoV-2 infectivity.Methods We collected 37 milk samples and 70 breast swabs (before and after breast washing) from 18 women recently diagnosed with COVID-19. Samples were analyzed for SARS-CoV-2 RNA using RT-qPCR. Milk was also analyzed for IgA and IgG specific for the nucleocapsid protein, receptor binding domain (RBD), S2 subunit of the spike protein of SARS-CoV-2, as well as 2 seasonal coronaviruses using ELISA; and for its ability to neutralize SARS-CoV-2.Results We did not detect SARS-CoV-2 RNA in any milk sample. In contrast, SARS-CoV-2 RNA was detected on several breast swabs, although only one was considered conclusive. All milk contained SARS-CoV-2-specific IgA and IgG, and levels of anti-RBD IgA correlated with SARS-CoV-2 neutralization. Strong correlations between levels of IgA and IgG to SARS-CoV-2 and seasonal coronaviruses were noted.Conclusions Our data do not support maternal-to-child transmission of SARS-CoV-2 via milk; however, risk of transmission via breast skin should be further evaluated. Importantly, milk produced by infected mothers is a source of anti-SARS-CoV-2 IgA and IgG and neutralizes SARS-CoV-2 activity. These results support recommendations to continue breastfeeding during mild-to-moderate maternal COVID-19 illness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a grant from the Bill and Melinda Gates Foundation, in-kind support from Medela and Milk Stork, US National Institutes of Health (R01 HD092297-03, U01 AI131344-04S1), Washington State University Health Equity Research Center, and the University of Idaho Agricultural Experiment Station.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants gave informed consent, and procedures were approved by the Institutional Review Boards at the University of Idaho (20-056, 20-060), the University of Rochester Medical Center (1507), and Brigham and Women's Hospital (2020P000804).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll requests for data and materials should be addressed to the corresponding authors.